glp 1 drugs adverse effects of GLP-1 Receptor Agonists Managing Side Effects of GLP-1
Description
Shah FA, Mahmud H, Gallego-Martin T, Jurczak MJ, ODonnell CP, McVerry BJ
Its lead pipeline drug, CagriSema (semaglutide and cagrilintide), is currently in Phase III development for obesity
According to research on the effects of semaglutide on appetite, many people report feeling full faster in addition to having less hunger
Kamal Patel, Department of Gastroenterology, St Georges University Hospital NHS Foundation Trust, London, United Kingdom
Primary prevention of cardiovascular and heart failure events With SGLT2 inhibitors, GLP-1 receptor agonists, and their combination in type 2 diabetes
